These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8037323)

  • 1. [The pathogenetic relationships between atypical hyperplasia, endometrial carcinoma and the E2 and progesterone levels].
    Gorchev G
    Akush Ginekol (Sofiia); 1993; 32(3):48-9. PubMed ID: 8037323
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum E2 and progesterone levels in patients with atypical hyperplasia and endometrial carcinoma].
    Gorchev G; Maleeva A
    Akush Ginekol (Sofiia); 1993; 32(2):23-4. PubMed ID: 8010393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of E2 and progesterone on the receptor status in endometrial carcinoma].
    Gorchev G; Milkov V; Tanchev S; Popov I
    Akush Ginekol (Sofiia); 1992; 31(2):27-8. PubMed ID: 1342552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sex hormones in the systemic and local circulation in endometrial hyperplasia and neoplasia: correlation with the activity of estrogen-metabolizing enzymes].
    Bochkareva NV; Kolomiets LA; Kondakova IV; Stukanov SL; Tropina TV; Muntian AB
    Vopr Onkol; 2008; 54(6):729-33. PubMed ID: 19241848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenetic basis of hormonal endometrial hypertrophy in early spontaneous abortions].
    Glukhovets BI; Glukhovets NG; Tarasov VN
    Arkh Patol; 2002; 64(5):28-31. PubMed ID: 12575538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Local hyperestradiolemia of the uterus in the pathogenesis of hyperplastic endometrial processes].
    Savitskiĭ GA
    Vopr Onkol; 1991; 37(2):179-84. PubMed ID: 2014696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pathogenetic basis for using antiestrogens in treating patients with hyperplastic processes of the endometrium in the postmenopause].
    Vysotskiĭ MM; Krasnova IA; Kostyleva OI; Eremin VL
    Akush Ginekol (Mosk); 1993; (6):46-9. PubMed ID: 8311159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
    Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
    Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems with the current diagnostic approach to complex atypical endometrial hyperplasia.
    Soslow RA
    Cancer; 2006 Feb; 106(4):729-31. PubMed ID: 16400641
    [No Abstract]   [Full Text] [Related]  

  • 10. Deciduoma formation in response to uterine trauma in the guinea pig.
    Mitchell JA; Garris DR
    Biol Reprod; 1978 Dec; 19(5):1135-41. PubMed ID: 570434
    [No Abstract]   [Full Text] [Related]  

  • 11. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen.
    de Lignieres B
    J Reprod Med; 1999 Feb; 44(2 Suppl):191-6. PubMed ID: 11392031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of insulin-like growth factor (IGF-I) and its binding protein (IGFBP-1) in pathological proliferation of endometrium.
    Waksmański B; Dudkiewicz J; Dabrowski S
    Wiad Lek; 2001; 54(11-12):656-61. PubMed ID: 11928553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women.
    Konishi I; Koshiyama M; Mandai M; Kuroda H; Yamamoto S; Nanbu K; Komatsu T; Matsushita K; Rao CV; Mori T
    Gynecol Oncol; 1997 May; 65(2):273-80. PubMed ID: 9159337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationship between simple and atypical endometrial hyperplasia and endometrial carcinoma].
    Borisov I; Maĭnkhard K; Tsankova M
    Akush Ginekol (Sofiia); 1996; 35(4):18-20. PubMed ID: 9254559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atypical endometrial hyperplasia. Prognosis and course].
    Jensen HH; Hussain SF; Pedersen PH; Andreasson B
    Ugeskr Laeger; 2000 Jan; 162(5):666-9. PubMed ID: 10707601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic endometrial hyperplasia/pyometra in dogs: a review of the causes and pathogenesis.
    Noakes DE; Dhaliwal GK; England GC
    J Reprod Fertil Suppl; 2001; 57():395-406. PubMed ID: 11787182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.